These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 24201777)

  • 1. Antiprotease strategy in pancreatic cancer treatment: emergence from a preclinical study.
    Brandi G; Tavolari S; Guarnieri T; Di Marco M; Paterini P; Macchini M; Di Girolamo S; Papi A; De Rosa F; Biasco G
    Pancreas; 2014 Jan; 43(1):53-63. PubMed ID: 24201777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Curcumin potentiates antitumor activity of gemcitabine in an orthotopic model of pancreatic cancer through suppression of proliferation, angiogenesis, and inhibition of nuclear factor-kappaB-regulated gene products.
    Kunnumakkara AB; Guha S; Krishnan S; Diagaradjane P; Gelovani J; Aggarwal BB
    Cancer Res; 2007 Apr; 67(8):3853-61. PubMed ID: 17440100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined effect of dehydroxymethylepoxyquinomicin and gemcitabine in a mouse model of liver metastasis of pancreatic cancer.
    Suzuki K; Aiura K; Matsuda S; Itano O; Takeuchi O; Umezawa K; Kitagawa Y
    Clin Exp Metastasis; 2013 Apr; 30(4):381-92. PubMed ID: 23111540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination chemotherapy of nafamostat mesilate with gemcitabine for pancreatic cancer targeting NF-kappaB activation.
    Uwagawa T; Chiao PJ; Gocho T; Hirohara S; Misawa T; Yanaga K
    Anticancer Res; 2009 Aug; 29(8):3173-8. PubMed ID: 19661331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gabexate mesilate, a synthetic anticoagulant, inhibits the expression of endothelial leukocyte adhesion molecules in vitro.
    Uchiba M; Okajima K; Kaun C; Binder BR; Wojta J
    Crit Care Med; 2003 Apr; 31(4):1147-53. PubMed ID: 12682486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. {Gamma}-tocotrienol inhibits pancreatic tumors and sensitizes them to gemcitabine treatment by modulating the inflammatory microenvironment.
    Kunnumakkara AB; Sung B; Ravindran J; Diagaradjane P; Deorukhkar A; Dey S; Koca C; Yadav VR; Tong Z; Gelovani JG; Guha S; Krishnan S; Aggarwal BB
    Cancer Res; 2010 Nov; 70(21):8695-705. PubMed ID: 20864511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Garcinol sensitizes human pancreatic adenocarcinoma cells to gemcitabine in association with microRNA signatures.
    Parasramka MA; Ali S; Banerjee S; Deryavoush T; Sarkar FH; Gupta S
    Mol Nutr Food Res; 2013 Feb; 57(2):235-48. PubMed ID: 23293055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Escin augments the efficacy of gemcitabine through down-regulation of nuclear factor-κB and nuclear factor-κB-regulated gene products in pancreatic cancer both in vitro and in vivo.
    Wang YW; Wang SJ; Zhou YN; Pan SH; Sun B
    J Cancer Res Clin Oncol; 2012 May; 138(5):785-97. PubMed ID: 22270965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nafamostat mesilate can prevent adhesion, invasion and peritoneal dissemination of pancreatic cancer thorough nuclear factor kappa-B inhibition.
    Fujiwara Y; Furukawa K; Haruki K; Shimada Y; Iida T; Shiba H; Uwagawa T; Ohashi T; Yanaga K
    J Hepatobiliary Pancreat Sci; 2011 Sep; 18(5):731-9. PubMed ID: 21484229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gemcitabine resistance induced by interaction between alternatively spliced segment of tenascin-C and annexin A2 in pancreatic cancer cells.
    Gong XG; Lv YF; Li XQ; Xu FG; Ma QY
    Biol Pharm Bull; 2010; 33(8):1261-7. PubMed ID: 20686216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Piperlongumine Suppresses Growth and Sensitizes Pancreatic Tumors to Gemcitabine in a Xenograft Mouse Model by Modulating the NF-kappa B Pathway.
    Wang Y; Wu X; Zhou Y; Jiang H; Pan S; Sun B
    Cancer Prev Res (Phila); 2016 Mar; 9(3):234-44. PubMed ID: 26667450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthetic serine protease inhibitor, gabexate mesilate, prevents nuclear factor-kappaB activation and increases TNF-alpha-mediated apoptosis in human pancreatic cancer cells.
    Takahashi H; Funahashi H; Sawai H; Matsuo Y; Yamamoto M; Okada Y; Takeyama H; Manabe T
    Dig Dis Sci; 2007 Oct; 52(10):2646-52. PubMed ID: 17357832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An undesired effect of chemotherapy: gemcitabine promotes pancreatic cancer cell invasiveness through reactive oxygen species-dependent, nuclear factor κB- and hypoxia-inducible factor 1α-mediated up-regulation of CXCR4.
    Arora S; Bhardwaj A; Singh S; Srivastava SK; McClellan S; Nirodi CS; Piazza GA; Grizzle WE; Owen LB; Singh AP
    J Biol Chem; 2013 Jul; 288(29):21197-21207. PubMed ID: 23740244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emodin potentiates the antitumor effects of gemcitabine in pancreatic cancer cells via inhibition of nuclear factor-κB.
    Liu A; Chen H; Tong H; Ye S; Qiu M; Wang Z; Tan W; Liu J; Lin S
    Mol Med Rep; 2011; 4(2):221-7. PubMed ID: 21468555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dimethylamino parthenolide enhances the inhibitory effects of gemcitabine in human pancreatic cancer cells.
    Holcomb BK; Yip-Schneider MT; Waters JA; Beane JD; Crooks PA; Schmidt CM
    J Gastrointest Surg; 2012 Jul; 16(7):1333-40. PubMed ID: 22618517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition and mechanism of action of a protease inhibitor in human pancreatic cancer cells.
    Uchima Y; Sawada T; Nishihara T; Maeda K; Ohira M; Hirakawa K
    Pancreas; 2004 Aug; 29(2):123-31. PubMed ID: 15257104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular evidence for increased antitumor activity of gemcitabine by genistein in vitro and in vivo using an orthotopic model of pancreatic cancer.
    Banerjee S; Zhang Y; Ali S; Bhuiyan M; Wang Z; Chiao PJ; Philip PA; Abbruzzese J; Sarkar FH
    Cancer Res; 2005 Oct; 65(19):9064-72. PubMed ID: 16204081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-21 modulates biological functions of pancreatic cancer cells including their proliferation, invasion, and chemoresistance.
    Moriyama T; Ohuchida K; Mizumoto K; Yu J; Sato N; Nabae T; Takahata S; Toma H; Nagai E; Tanaka M
    Mol Cancer Ther; 2009 May; 8(5):1067-74. PubMed ID: 19435867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypoxia increases resistance of human pancreatic cancer cells to apoptosis induced by gemcitabine.
    Yokoi K; Fidler IJ
    Clin Cancer Res; 2004 Apr; 10(7):2299-306. PubMed ID: 15073105
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycogen synthase kinase-3 inhibition disrupts nuclear factor-kappaB activity in pancreatic cancer, but fails to sensitize to gemcitabine chemotherapy.
    Mamaghani S; Patel S; Hedley DW
    BMC Cancer; 2009 Apr; 9():132. PubMed ID: 19405981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.